Earnings
YMTX
18.06
+2.03%
0.36
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2019-12-31
5.00M
5.00M
--
--
13.84M
52.32M
--
--
--
66.15M
--
-61.15M
1.09M
--
936.00K
1.09M
-59.13M
--
-59.13M
--
-59.13M
-59.13M
--
--
-23.12
FY 2018-12-31
2.84M
2.84M
--
--
15.71M
50.31M
--
--
--
66.02M
--
-63.18M
872.00K
--
478.00K
872.00K
-61.83M
--
-61.83M
--
-61.83M
-61.83M
--
--
-32.12
FY 2017-12-31
5.34M
5.34M
--
--
11.66M
53.65M
--
--
--
65.31M
--
-59.97M
641.00K
--
-100.00K
641.00K
-59.43M
0.00
-59.43M
--
-59.43M
-59.43M
0.00
--
-46.78
FY 2016-12-31
8.38M
8.38M
--
--
11.88M
33.96M
--
--
--
45.84M
--
-37.45M
246.00K
--
-23.00K
246.00K
-37.23M
--
-37.23M
--
-37.23M
-38.61M
--
--
-41.16
FY 2015-12-31
4.31M
4.31M
--
--
6.32M
22.52M
--
--
--
28.85M
--
-24.53M
-599.00K
--
93.00K
-599.00K
-25.04M
--
-25.04M
--
-25.04M
-23.31M
--
--
-24.39

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out YMTX latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze Yumanity Therapeutics Inc recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.